文献速递胃肠外科

单孔与多孔腹腔镜远端胃癌根治术的随机对照试验

A randomized controlled trial of single-port versus multi-port laparoscopic distal gastrectomy for gastric cancer.
PubMed 文献 · Surg Endosc · 2020-09-04

结果显示SLG组术后疼痛评分显著更低,镇痛药使用更少、使用时间更短,手术时间更短,其他手术结局相当。

要点

  • SLG组术后疼痛评分在手术当日及术后第1-7天均显著低于MLG组(p<0.001)。
  • SLG组镇痛药使用天数更少(1 vs. 3天,p=0.0078),使用持续时间更短(2 vs. 3天,p=0.0171)。
  • SLG组手术时间显著短于MLG组(169 vs. 182分钟,p=0.0399),其他手术结局相当。

核心结论

  • SLG在临床I期胃癌治疗中安全可行,短期结果更优,表现为疼痛更轻。

主要发现

  • SLG组术后疼痛评分在手术当日及术后第1-7天显著低于MLG组(p<0.001)。
  • SLG组镇痛药使用显著更少(1 vs. 3天,p=0.0078),使用持续时间显著更短(2 vs. 3天,p=0.0171)。
  • SLG组手术时间显著更短(169 vs. 182分钟,p=0.0399),其他手术结局两组相当。

临床怎么用

  • 对于临床I期胃癌,SLG可作为一种安全可行的术式选择,可能减轻术后疼痛并减少镇痛药使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This prospective randomized trial compared the invasiveness of laparoscopic gastrectomy using a single-port approach with that of a conventional multi-port approach in the treatment of gastric cancer. The benefit of single-port laparoscopic gastrectomy (SLG) over multi-port laparoscopic gastrectomy (MLG) has yet to be confirmed in a well-designed study. METHODS: One hundred and one patients who were scheduled to undergo laparoscopic distal gastrectomy for histologically confirmed clinical stage I gastric cancer between April 2016 and September 2018 were randomly allocated to SLG (n = 50) or MLG (n = 51). The primary endpoints were the postoperative visual analog scale pain scores. Secondary endpoints were frequency of use of analgesia, short-term outcomes, such as operating time, intraoperative blood loss, inflammatory reactions, postoperative morbidity, and 90-day mortality. RESULTS: The postoperative pain score was significantly lower in the SLG group than in the MLG group (p < 0.001) on the operative day and the postoperative day 1-7. Analgesics were administered significantly less often in the SLG group than in the MLG group (1 vs. 3 days, p = 0.0078) and the duration of use of analgesics was significantly shorter in the SLG group (2 vs. 3 days, p = 0.0171). The operating time was significantly shorter in the SLG group than in the MLG group (169 vs. 182 min, p = 0.0399). Other surgical outcomes were comparable between the study groups. CONCLUSIONS: SLG was shown to be safe and feasible in the treatment of gastric cancer with better short-term results in terms of less severe pain and may be suitable for treatment of cStage I gastric cancer. CLINICAL TRIAL REGISTRATION: UMIN000022218.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Omori T, Yamamoto K, Hara H, et al. A randomized controlled trial of single-port versus multi-port laparoscopic distal gastrectomy for gastric cancer. Surg Endosc. 2020. PMID: 32886237. doi:10.1007/s00464-020-07955-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。